Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Stacy J. Keding
Introduction
Stacy J. Keding is a notable inventor based in New York, NY, recognized for her significant contributions to the field of cancer research. With two patents to her name, she has made strides in developing innovative solutions for cancer treatment and prevention, focusing on novel glycosides and anti-cancer strategies.
Latest Patents
Stacy J. Keding’s latest patents include:
1. **Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof** - This patent presents novel glycosides and glycoconjugates, glycoamino acids, and methods for their synthesis. Additionally, it offers methods for the treatment of cancer, specifically targeting the prevention of cancer recurrence and promoting antibody induction in subjects through the administration of inventive glycopeptides.
2. **Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof** - This invention focuses on clustered multi-antigenic constructs, detailing their structural composition and preparation methods, aimed at enhancing immune responses against cancer.
Career Highlights
Stacy J. Keding currently works at the Sloan Kettering Institute for Cancer Research, a leading research institution dedicated to cancer study and treatment. Her work has garnered attention for its potential to significantly improve patient outcomes through innovative therapeutic strategies.
Collaborations
Throughout her career, Stacy has collaborated with prominent colleagues such as Samuel J. Danishefsky and Don M. Coltart. These collaborations are vital in advancing her research and expanding the impact of her inventions in the scientific community.
Conclusion
Stacy J. Keding's innovative work is paving the way for new treatments in cancer therapy. With her patents focusing on glycosides and multi-antigenic constructs, she continues to contribute to the evolution of medical science, demonstrating the vital interplay between innovation and health care. Her efforts at the Sloan Kettering Institute for Cancer Research place her at the forefront of cancer research, solidifying her status as a leading inventor in this essential field.